Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-01-02
2007-01-02
Lambkin, Deborah C. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S134000
Reexamination Certificate
active
10511915
ABSTRACT:
Compounds of formula I: wherein X represents a 5-(R-substituted)-1,2,4-oxadiazole-3-yl moiety are inhibitors of gamma-secretase, and hence useful for treating Alzheimer's disease
REFERENCES:
patent: 7041688 (2006-05-01), Campbell et al.
patent: 7041689 (2006-05-01), Collins et al.
patent: 7078424 (2006-07-01), Hamilton et al.
patent: WO 01/70677 (2001-09-01), None
patent: WO 02/36555 (2002-05-01), None
Collins Ian James
Cooper Laura Catherine
Lambkin Deborah C.
Merck Sharp & Dohme Ltd.
Todaro John C.
Winokur Melvin
LandOfFree
Oxadiazole derivatives for inhibition of gamma secretase does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oxadiazole derivatives for inhibition of gamma secretase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oxadiazole derivatives for inhibition of gamma secretase will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3818393